A new study found that a one-two punch of cholesterol-lowering drugs could significantly reduce the risk of a stroke and ...

The largest analysis to examine the best way to lower levels of "bad" cholesterol in patients with blocked arteries shows ...

The largest analysis to examine the best way to lower levels of 'bad' cholesterol in patients with blocked arteries shows ...

TAKING two common drugs together could slash your levels of ‘bad’ cholesterol and lower the risk of death from heart attack and stroke, a study showed. This method of treating high ...

Arrest-ed development? Heart disease is the leading cause of death in the US, killing around 700,000 Americans each year. New ...

A combination of two widely available drugs could significantly reduce deaths from heart attacks, a study has found.  New ...

Harvard Medical School researchers have found that statin use significantly reduces the risk of hepatocellular carcinoma (HCC ...

HealthDay News — For patients with chronic liver disease, statin use is associated with a reduced risk for hepatocellular carcinoma (HCC) and hepatic decompensation, according to a study published ...

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and ...

When the U.S. Food and Drug Administration (FDA) approved rosuvastatin, early reports indicated that it could cause blood ...

In the large clinical trials that proved the benefits of statins, about a quarter of people complained of myalgia, although most of these cases did not appear to be caused by the statin itself.

Improving Global Outcomes organization's updates to its 2024 guidelines expand SGLT2 inhibitor use and refine chronic kidney ...